Rasayana

TL;DR

The Ayurvedic science of rejuvenation and longevity — using potent herbo-mineral formulations and lifestyle practices to preserve telomere length, activate AMPK/SIRT1, modulate mTOR, and upregulate BDNF. Key formulations (Chyawanprash, Brahma Rasayana) have RCT evidence; herbo-mineral bhasmas are potent but require rigorous heavy metal testing. Classical prerequisite: Panchakarma must precede Rasayana administration.

Why it matters for Vitals

Rasayana directly targets hallmarks of aging: telomere attrition (Amalaki Rasayana → telomerase upregulation), mitochondrial dysfunction (AMPK/SIRT1 activation), immunosenescence (Chyawanprash NK cell data), and cognitive decline (Brahma Rasayana BDNF/GDS data). The AMPK/mTOR modulation profile is directly relevant to Vitals metabolic coaching and body composition logic.

Key Facts

Status	Traditional therapy; accelerating modern scientific validation
Class	Rejuvenation therapy (Ayurvedic geriatrics + epigenetic modulation)
Core mechanism	Multi-pathway: AMPK/SIRT1 activation, mTOR balancing, NF-κB inhibition, telomerase upregulation
Key benefits	Cognitive preservation, immune resilience, delay of cellular senescence, improved anabolic recovery, stress adaptation
Dosing	Individualized; 12–48 g/day (polyherbal jams); 90-day cycles common
Main risks	Heavy metal toxicity in bhasma preparations; over-nourishing in acute illness
Evidence level	Moderate to Strong for Chyawanprash, Brahma Rasayana, individual herbs (Ashwagandha, Brahmi); emerging telomere data
Prerequisite	Panchakarma clearance of Ama before administration

Core Mechanism — Longevity Pathway Modulation

AMPK & SIRT1 activation: Guduchi and Ashwagandha act as caloric restriction mimetics → shifts metabolism from anabolism to catabolism (promoting repair). Resveratrol (in Draksha/grapes) and withanolides induce SIRT1 → enhanced mitochondrial biogenesis + DNA repair.

mTOR modulation: Unlike high-dose Rapamycin which severely suppresses growth/immunity, Rasayanas activate AMPK → gently suppress hyperactive mTORC1 → stimulate autophagy + clear senescent cells, while allowing sufficient intermittent mTOR signaling for healthy tissue repair (Dhatuposhana).

NF-κB inhibition: Chyawanprash inhibits NF-κB signaling → downregulates IL-6 and TNF-α.

Telomere protection: Amalaki Rasayana (45 days, n=healthy 45–60 yr) → statistically significant telomerase upregulation in peripheral blood mononuclear cells vs control. Ashwagandha root extract: +45% telomerase activity in vitro.

BDNF upregulation: Medhya Rasayanas (Brahmi, Gotu Kola) upregulate hippocampal BDNF via SIRT1/BDNF axis → neurogenesis, synaptic plasticity.

Key Formulas

Chyawanprash (CP)

Polyherbal jam with Amalaki (Indian Gooseberry) base + 40+ botanicals in ghee/honey/sesame oil.

Mechanisms: NF-κB inhibition → ↓ IL-6, TNF-α; high vitamin C + polyphenols → cytoprotection.

Clinical data:

• Adjunct to anti-tubercular drugs: accelerated symptom resolution + weight gain
• COVID-19 prophylactic RCT: significant reduction in infection incidence and severity
• Multi-fold increases in macrophage and NK cell activity in healthy populations

Brahma Rasayana

Amalaki + Haritaki + nootropic herbs (Brahmi, Shankhapushpi, Vacha).

Clinical data:

• Geriatric depression (60–80 yr, 28 days): 28.5% GDS remission rate; quality-of-life improvements
• Physical stamina: 41% improvement in sleep architecture; 37% increase in exertional capacity (45 days)

Herbo-Mineral Bhasmas

Purified metals/minerals processed through Shodhana + Marana (up to 100 cycles at 1000°C) → bioavailable nanoparticles (20–100 nm).

• Swarna Bhasma (Gold): Deep immune modulation, rheumatoid arthritis, cognitive enhancement; NOEL at 13.5 mg/kg (rat)
• Rajata Bhasma (Silver): Antimicrobial, neurological resilience, anxiety
• Lauha Bhasma (Iron): Anemia — mixed Fe(II)/Fe(III) states → enhanced hemoglobin regeneration with less GI irritation than ferrous sulfate

Safety and Contraindications

• Acute illness and Ama: Rasayanas are deeply nourishing (anabolic). Administering during fever or acute infection “feeds the pathogen.”
• Prakriti incompatibilities: Highly thermogenic Rasayanas (Shilajit, Pippali) contraindicated in extreme Pitta imbalance; over-nourishing Rasayanas require caution in obese/Kapha-stagna
• Pregnancy/lactation: Bhasmas require clinical specialist only
• Drug interactions: Guduchi may interfere with immunosuppressants; Amalaki/Shilajit may compound hypoglycemic medications

Heavy Metal Testing — Mandatory

Improperly manufactured bhasmas = primary real-world hazard.

WHO/AYUSH limits:

• Lead (Pb): max 10.0 ppm
• Arsenic (As): max 3.0 ppm (AYUSH stricter than WHO)
• Cadmium (Cd): max 0.3 ppm
• Mercury (Hg): max 1.0 ppm

Required: Batch-specific CoA via ICP-MS; WHO-GMP certification; ISO 18664:2015 testing.

Cycling Strategies

• Vardhamana (escalating): Minimal start → peak → symmetric taper (used for Shilajit, Pippali)
• Duration: 90 days on, washout period to prevent receptor downregulation
• Ajasrika: Food-based Rasayanas (milk, ghee, honey) — can be maintained perpetually
• Kutipraveshika: Intensive indoor protocol — requires specialized facility and supervision

Inside this hub

• Individual herb monographs (Ashwagandha, Brahmi, Shatavari) — get their own notes when individually researched
• Shilajit — enough substance for its own note when researched
• Specific phytochemical isolation details — kept here
• Dhatu nourishment protocols — too procedural

Related notes

• Ayurveda — parent system
• Panchakarma — prerequisite detoxification; Rasayana must follow Ama clearance
• BDNF NGF induction — shared neurotrophin mechanism with Medhya Rasayanas
• Mitophagy — shared with AMPK/SIRT1 activation
• [Telomerase] — shared telomere mechanism
• Rapamycin — comparison: mTOR inhibition context
• NMN NAD+ — complementary SIRT1 activation pathway